| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Molecular Targets, and Chemical Biology |
1 Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland; 2 King's College London, Department of Haematological Medicine, Leukemia Sciences Laboratories, The Rayne Institute, GKT School of Medicine, Denmark Hill Campus, London, United Kingdom; 3 School of Biosciences, Cardiff University, Cardiff, United Kingdom; and 4 INSERM U718, Institût Universitaire d'Hématologie, IFR 105, Hôpital Saint-Louis, Paris, France
Requests for reprints: Feyruz Rassool, University of Maryland School of Medicine, Department of Radiation Oncology, 655 West Baltimore Street, BRB 7-009, Baltimore, MD 21201-1509. Phone: 410-706-5337; Fax: 410-706-3000; E-mail: frassool{at}som.umaryland.edu or Rose Ann Padua, Institut National de la Sante et de la Recherche Medicale (INSERM) U718, Institût Universitaire d'Hématologie, Hôpital Saint Louis, 75010 Paris, France. Phone: 33-1-53-72-40-18; Fax: 33-1-53-72-40-16.
Myelodysplastic syndromes (MDS) comprise a heterogeneous group of disorders characterized by ineffective hematopoiesis, with an increased propensity to develop acute myelogenous leukemia (AML). The molecular basis for MDS progression is unknown, but a key element in MDS disease progression is loss of chromosomal material (genomic instability). Using our two-step mouse model for myeloid leukemic disease progression involving overexpression of human mutant NRAS and BCL2 genes, we show that there is a stepwise increase in the frequency of DNA damage leading to an increased frequency of error-prone repair of double-strand breaks (DSB) by nonhomologous end-joining. There is a concomitant increase in reactive oxygen species (ROS) in these transgenic mice with disease progression. Importantly, RAC1, an essential component of the ROS-producing NADPH oxidase, is downstream of RAS, and we show that ROS production in NRAS/BCL2 mice is in part dependent on RAC1 activity. DNA damage and error-prone repair can be decreased or reversed in vivo by N-acetyl cysteine antioxidant treatment. Our data link gene abnormalities to constitutive DNA damage and increased DSB repair errors in vivo and provide a mechanism for an increase in the error rate of DNA repair with MDS disease progression. These data suggest treatment strategies that target RAS/RAC pathways and ROS production in human MDS/AML. [Cancer Res 2007;67(18):8762–71]
This article has been cited by other articles:
![]() |
C. Cavelier, C. Didier, N. Prade, V. Mansat-De Mas, S. Manenti, C. Recher, C. Demur, and B. Ducommun Constitutive Activation of the DNA Damage Signaling Pathway in Acute Myeloid Leukemia with Complex Karyotype: Potential Importance for Checkpoint Targeting Therapy Cancer Res., November 15, 2009; 69(22): 8652 - 8661. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, N. Mitsutake, K. LaPerle, N. Akeno, P. Zanzonico, V. A. Longo, S. Mitsutake, E. T. Kimura, H. Geiger, E. Santos, et al. Endogenous expression of HrasG12V induces developmental defects and neoplasms with copy number imbalances of the oncogene PNAS, May 12, 2009; 106(19): 7979 - 7984. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fontenay and E. Gyan Apoptotic pathways to death in myelodysplastic syndromes Haematologica, September 1, 2008; 93(9): 1288 - 1292. [Full Text] [PDF] |
||||
![]() |
H. Kadara, E. Tahara, H.-J. Kim, D. Lotan, J. Myers, and R. Lotan Involvement of Rac in Fenretinide-Induced Apoptosis Cancer Res., June 1, 2008; 68(11): 4416 - 4423. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sallmyr, J. Fan, K. Datta, K.-T. Kim, D. Grosu, P. Shapiro, D. Small, and F. Rassool Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML Blood, March 15, 2008; 111(6): 3173 - 3182. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |